BDX Surges 32.71% in Trading Volume Ranked 303rd as Shares Dip 2.12%

On August 28, 2025, Becton, Dickinson and Company (BDX) saw a trading volume of $0.34 billion, marking a 32.71% increase from the prior day and ranking it 303rd in market activity. The stock closed lower by 2.12%, reflecting investor sentiment amid broader market dynamics.

Becton operates across three core segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical division focuses on vascular access, infusion systems, and drug delivery solutions, while BD Life Sciences caters to diagnostic and research needs with products like blood culturing systems and single-cell analysis tools. The BD Interventional segment addresses surgical and critical care markets, offering hernia repair and biosurgery products. Established in 1897, the company serves a global client base spanning healthcare institutions, pharmaceutical firms, and life science researchers.

Query limit exceeded.